» Articles » PMID: 28451516

Antibiotic Resistance: What is So Special About Multidrug-resistant Gram-negative Bacteria?

Abstract

In the past years infections caused by multidrug-resistant Gram-negative bacteria have dramatically increased in all parts of the world. This consensus paper is based on presentations, subsequent discussions and an appraisal of current literature by a panel of international experts invited by the Rudolf Schülke Stiftung, Hamburg. It deals with the epidemiology and the inherent properties of Gram-negative bacteria, elucidating the patterns of the spread of antibiotic resistance, highlighting reservoirs as well as transmission pathways and risk factors for infection, mortality, treatment and prevention options as well as the consequences of their prevalence in livestock. Following a global, One Health approach and based on the evaluation of the existing knowledge about these pathogens, this paper gives recommendations for prevention and infection control measures as well as proposals for various target groups to tackle the threats posed by Gram-negative bacteria and prevent the spread and emergence of new antibiotic resistances.

Citing Articles

High incidence of multidrug-resistant organisms and modifiable risk factors associated with surgical site infections: a cohort study in a tertiary medical center in Kuala Lumpur, Malaysia from 2020 to 2023.

Muhamad A, Teh C, Draman M, Adnan Y, Abbas A, Khong T Antimicrob Resist Infect Control. 2025; 14(1):22.

PMID: 40082971 PMC: 11907968. DOI: 10.1186/s13756-025-01537-2.


β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development.

Katsarou A, Stathopoulos P, Tzvetanova I, Asimotou C, Falagas M Pathogens. 2025; 14(2).

PMID: 40005543 PMC: 11858600. DOI: 10.3390/pathogens14020168.


Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria.

Goncalves R, Monges B, Oshiro K, Candido E, Pimentel J, Franco O ACS Infect Dis. 2025; 11(2):323-334.

PMID: 39855154 PMC: 11833863. DOI: 10.1021/acsinfecdis.4c00702.


Prevalence and genetic characterization of clinically relevant extended-spectrum β-lactamase-producing in the Gulf Cooperation Council countries.

Hadi H, Al-Hail H, Aboidris L, Al-Orphaly M, Ahmed M, Samuel B Front Antibiot. 2025; 2():1177954.

PMID: 39816644 PMC: 11732020. DOI: 10.3389/frabi.2023.1177954.


The effect of combining antibiotics on resistance: A systematic review and meta-analysis.

Siedentop B, Kachalov V, Witzany C, Egger M, Kouyos R, Bonhoeffer S Elife. 2024; 13.

PMID: 39704726 PMC: 11661791. DOI: 10.7554/eLife.93740.


References
1.
Stock I . [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy]. Med Monatsschr Pharm. 2014; 37(5):162-72. View

2.
Irrgang A, Roschanski N, Tenhagen B, Grobbel M, Skladnikiewicz-Ziemer T, Thomas K . Prevalence of mcr-1 in E. coli from Livestock and Food in Germany, 2010-2015. PLoS One. 2016; 11(7):e0159863. PMC: 4959773. DOI: 10.1371/journal.pone.0159863. View

3.
Hawkey P, Jones A . The changing epidemiology of resistance. J Antimicrob Chemother. 2009; 64 Suppl 1:i3-10. DOI: 10.1093/jac/dkp256. View

4.
Strauss L, Dahms C, Becker K, Kramer A, Kaase M, Mellmann A . Development and evaluation of a novel universal β-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli. J Antimicrob Chemother. 2014; 70(3):710-5. DOI: 10.1093/jac/dku450. View

5.
Mayr-Kanhauser S, Kranke B, Aberer W . Efficacy of octenidine dihydrochloride and 2-phenoxyethanol in the topical treatment of inflammatory acne. Acta Dermatovenerol Alp Pannonica Adriat. 2008; 17(3):139-43. View